Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2017

Aug 3, 2017

29777_dirs_2017-08-03_ab9bb739-e862-41ef-9e28-0d055a2831bb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-08-01

Reporting Person: Bracken Sharon J (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-01 Common shares without par value S 400 $49.165 Disposed 28806 Direct
2017-08-01 Common shares without par value S 600 $49.16 Disposed 28206 Direct
2017-08-01 Common shares without par value S 1000 $49.161 Disposed 27206 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 736 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 1, 2017.